Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 19;4(12):e006720.
doi: 10.1136/bmjopen-2014-006720.

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

Sigrun Alba Johannesdottir Schmidt  1 , Martin Berg Johansen  1 , Morten Olsen  1 , Xiao Xu  2 , Joseph M Parker  3 , Nestor A Molfino  4 , Timothy L Lash  5 , Henrik Toft Sørensen  1 , Christian Fynbo Christiansen  1
Affiliations

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

Sigrun Alba Johannesdottir Schmidt et al. BMJ Open. .

Abstract

Objective: To examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Design: Cohort study using medical databases.

Setting: Northern Denmark.

Participants: On 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease (COPD) who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency (0, 1, 2 or 3+) in the prior 12-month period.

Main outcomes and measures: Using Cox regression, we computed 0-30-day and 31-365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios (MRRs) with 95% CIs entering exacerbation frequency as a time-varying exposure.

Results: We identified 16,647 eligible patients with prevalent COPD, of whom 6664 (40%) developed an AECOPD and were thus included in the study cohort. The 0-30-day MRRs were 0.97 (95% CI 0.80 to 1.18), 0.90 (95% CI 0.70 to 1.15) and 1.03 (95% CI 0.81 to 1.32) among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 (95% CI 1.30 to 1.66), 1.89 (95% CI 1.59 to 2.25) and 1.59 (95% CI 1.23 to 2.05) for days 31-365.

Conclusion: Among patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31-365-day mortality.

Keywords: Cohort study; Registry study; Severe exacerbations; Time-varying exposure.

PubMed Disclaimer

References

    1. Donaldson GC, Wedzicha JA. COPD exacerbations.1: Epidemiology. Thorax 2006;61:164–8. 10.1136/thx.2005.041806 - DOI - PMC - PubMed
    1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341–51. 10.1016/S0140-6736(11)60968-9 - DOI - PMC - PubMed
    1. Lash TL, Johansen MB, Christensen S et al. . Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 2010;189:27–35. 10.1007/s00408-010-9274-z - DOI - PubMed
    1. Juel K, Drøssing M [Chronic obstructive pulmonary disease]. Public Health Report, Denmark, 2007.
    1. From the Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (updated 2013). http://www.goldcopd.org/ (accessed 28 Apr 2013).

Publication types